Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ramipril
Drug ID BADD_D01909
Description Ramipril is a prodrug belonging to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to ramiprilat in the liver and, to a lesser extent, kidneys. Ramiprilat is a potent, competitive inhibitor of ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Ramipril may be used in the treatment of hypertension, congestive heart failure, nephropathy, and to reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events.
Indications and Usage For the management of mild to severe hypertension. May be used to reduce cardiovascular mortality following myocardial infarction in hemodynamically stable individuals who develop clinical signs of congestive heart failure within a few days following myocardial infarction. To reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events. May be used to slow the progression of renal disease in individuals with hypertension, diabetes mellitus and microalubinuria or overt nephropathy.
Marketing Status Prescription; Discontinued
ATC Code C09AA05
DrugBank ID DB00178
KEGG ID D00421
MeSH ID D017257
PubChem ID 5362129
TTD Drug ID D01STB
NDC Product Code 50090-5947; 68001-430; 82348-101; 70518-3038; 65862-477; 68382-146; 68382-147; 62135-272; 61570-112; 65841-699; 15308-0300; 61919-157; 76282-673; 57237-223; 63187-277; 68382-144; 71205-029; 0054-0106; 51655-346; 57237-222; 68001-428; 55111-438; 71335-1057; 65862-476; 69037-0051; 65862-320; 63187-854; 76282-671; 0054-0109; 68382-375; 68382-374; 51655-347; 51655-144; 71205-080; 0054-0107; 65862-474; 65862-475; 16729-152; 45865-443; 50090-3059; 55111-440; 63187-644; 17404-1021; 45865-441; 65841-655; 68001-431; 57237-224; 57237-225; 68180-590; 61570-110; 71335-1056; 50090-1118; 60760-481; 0054-0108; 63187-073; 60760-571; 50090-5673; 68001-429; 53104-7573; 71335-0894; 63629-1254; 65841-701; 68382-377; 62135-274; 61570-120; 68382-145; 55111-439; 63187-915; 63187-816; 50090-5730; 68180-591; 50090-4597; 62135-273; 16729-155; 61570-111; 65841-657; 68554-0004; 50090-4691; 65841-658; 12854-207; 16729-153; 68382-376; 65841-702; 16729-154; 55111-441; 62135-271; 65841-656; 60760-477; 76282-672; 76282-670; 50090-3873; 61919-179; 65841-700; 70518-1200; 55111-057; 63187-503; 60760-476; 58032-0123; 55700-551; 68180-589
Synonyms Ramipril | Vesdil | Triatec | Altace | Zabien | Ramace | Tritace | Acovil | Delix | Carasel | HOE-498 | HOE 498 | HOE498
Chemical Information
Molecular Formula C23H32N2O5
CAS Registry Number 87333-19-5
SMILES CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Blood pressure decreasedAngiotensin-converting enzymeP12821T8257716395257; 16138565; 9270093; 10535720; 9726242; 10620209; 10880412; 8986921; 10999650
CoughB2 bradykinin receptorP30411T2371410904024; 12522467; 11699055; 15894833
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anxiety19.06.02.002--
Aphasia19.21.01.001; 17.02.03.0010.000999%
Aphonia22.02.05.024; 19.19.01.002; 17.02.08.0090.000400%
Aphthous ulcer07.05.06.0020.000799%Not Available
Apnoea22.02.01.0010.000999%
Arrhythmia02.03.02.0010.002598%Not Available
Arthralgia15.01.02.0010.005796%
Arthritis15.01.01.001--
Arthropathy15.01.01.003--Not Available
Ascites09.01.05.003; 07.07.01.001; 02.05.04.0020.000799%
Aspartate aminotransferase increased13.03.01.006--
Asphyxia22.02.02.001; 12.01.08.0110.000156%Not Available
Aspiration22.02.07.0070.000104%
Asthenia08.01.01.0010.007595%Not Available
Asthma10.01.03.010; 22.03.01.0020.001599%Not Available
Atrial fibrillation02.03.03.0020.003198%
Atrial septal defect03.07.02.002; 02.04.02.0090.002198%Not Available
Atrioventricular block02.03.01.0020.000600%Not Available
Atrioventricular block complete02.03.01.0030.000600%
Atrioventricular block second degree02.03.01.0050.000400%
Back pain15.03.04.005--
Basal cell carcinoma16.03.02.001; 23.08.02.0010.000400%Not Available
Bile duct stone09.02.02.0030.000799%Not Available
Bilirubin conjugated increased13.03.01.007--Not Available
Blister23.03.01.001; 12.01.06.0020.001199%Not Available
Blood bilirubin increased13.03.01.0080.001999%
Blood chloride decreased13.11.01.0040.000400%Not Available
Blood cholesterol increased13.12.01.002--
Blood creatine increased13.13.01.001--Not Available
Blood creatine phosphokinase increased13.04.01.0010.001399%
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 24 Pages